RICHARD SNOUFFER: Open Payments
NPI 1821006628 · OXFORD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 47 payments from 12 companies in 2025. Trend: 2023 $949 · 2024 $843 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $276 |
| Novo Nordisk Inc | 5 | $127 |
| Braeburn Inc. | 6 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Indivior Inc. | 3 | $64 |
| Antares Pharma, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
Products named: VRAYLAR, BRIXADI, UBRELVY, Ozempic, CAPLYTA, SUBLOCADE, Wegovy, XYOSTED.
Industry payments across AL — which companies pay providers there.
